Google hep C
Google News
Updated: 10 hours 10 min ago
Is acupuncture a risk factor for hepatitis C in Asian patients? - Pulse (blog)
Is acupuncture a risk factor for hepatitis C in Asian patients?
Pulse (blog)
A Californian team investigated 494 patients with hepatitis C in order to determine the risk factors for this infection. 1 Specifically they wanted to find out whether the risk factors differ between various ethnic groups.
Categories: In the News
Aethlon Medical to Present Hepatitis C (HCV) Treatment Technology at the 32nd ... - MarketWatch (press release)
Aethlon Medical to Present Hepatitis C (HCV) Treatment Technology at the 32nd ...
MarketWatch (press release)
The clearance of circulating hepatitis C virions, including mutant strains, would inhibit the continued replication of drug-resistant viruses and decrease the likelihood of early onset resistance to emerging all-antiviral strategies.
and more »
Categories: In the News
As death nears, hepatitis C victim to give videotaped deposition in Desai case - Las Vegas Review-Journal
As death nears, hepatitis C victim to give videotaped deposition in Desai case
Las Vegas Review-Journal
Rodolfo Meana, pictured here in 2008, is one of seven patients diagnosed with hepatitis C that has been genetically linked to the Endoscopy Center of Southern Nevada. Meana's doctors have told him he is terminally ill. » Buy this photo Dr. Dipak Desai ...
and more »
Categories: In the News
BioLineRx shares soar (again) on hep C pact; Anacor shares slide after GSK ... - FierceBiotech
BioLineRx shares soar (again) on hep C pact; Anacor shares slide after GSK ...
FierceBiotech
Article | Follow @FierceBiotech @JohnCFierce: So does BioLineRx see itself as a hep C co. now that it has in-licensed a 2nd program, or is this about share price? Release | Follow @JohnCFierce @FierceMedDev: DNA-sequencing penetrates Norway's ...
and more »
Categories: In the News
BioLineRX soars on second hepatitis C deal - MarketWatch
BioLineRX soars on second hepatitis C deal
MarketWatch
By Val Brickates Kennedy BOSTON (MarketWatch) -- Shares of BioLineRx soared 33% to $5.49 on Monday on news that the Israeli drug developer has licensed an experimental treatment for hepatitis C, dubbed BL-8030, from Genoscience and RFS Pharma.
Categories: In the News
Gilead Sciences Jumps on Hepatitis C Data - Pharmaceutical Processing
Gilead Sciences Jumps on Hepatitis C Data
Pharmaceutical Processing
NEW YORK (AP) — Shares of Gilead Sciences Inc. jumped Friday after the company reported further progress of GS-7977, a newly-acquired hepatitis C treatment still in clinical testing. THE SPARK: Gilead said Thursday that in a clinical trial, ...
Does Anavex Life Sciences (AVXL) Have the Next Big Thing Big Pharma Wants?SmallCap Network
Positive Clinical Trial Results Boost Gilead the Most in Three Years – NASDAQ:GILDGalaxy Stocks
Gilead stock rises on potential hepatitis C cureSan Francisco Business Times (blog)
Proactive Investors USA & Canada -Seeking Alpha -CNBC.com
all 11 news articles »
Categories: In the News
BioLineRx Licenses Another Hepatitis C Drug From Genoscience - Wall Street Journal
BioLineRx Licenses Another Hepatitis C Drug From Genoscience
Wall Street Journal
BioLineRx Ltd. (BLRX) licensed another Hepatitis C treatment from French biotechnology company Genoscience, as the Israeli-based biopharmaceutical company expands into the field of Hepatitis C therapeutics. Hepatitis C is a blood-borne infection of the ...
Closer Look: BioLineRx Snags Another Hep-C License AgreementSeeking Alpha
BiolineRX signs second hepatitis C licensing dealGlobes
BioLineRx signs licensing deal with Genoscience, RFS PharmaPharmaceutical Business Review
Galaxy Stocks
all 27 news articles »
Categories: In the News
Gilead Rises on Hepatitis C Trial Results: San Francisco Mover - BusinessWeek
RTT News
Gilead Rises on Hepatitis C Trial Results: San Francisco Mover
BusinessWeek
3 (Bloomberg) -- Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc. last month for its experimental hepatitis C treatments, gained the most in three years after one of the medicines produced positive clinical trial results.
Gilead Woes With New Hep C Data, Boxing Out Poor 2012 GuidanceTheStreet.com
Gilead shares surge as hep C drug scores a cure for big patient populationFierceBiotech
An all-oral hepatitis C drug may be one step closer to realityLagonian.com
Barron's (blog) -Motley Fool
all 63 news articles »
Categories: In the News
Idenix gets good news on hep C trial, but can't compete with Gilead - FierceBiotech
Citybizlist
Idenix gets good news on hep C trial, but can't compete with Gilead
FierceBiotech
Idenix put out the news this morning that the FDA had lifted a partial hold on its hepatitis C drug IDX184--and then watched its share price slide. In a sign of just how volatile the whole hepatitis C arena has become after back-to-back blockbuster ...
Idenix Falls Casualty to Gilead Hep C HooplaTheStreet.com
Idenix: FDA lifts partial hold on hepatitis C drugMarketWatch
Idenix Says FDA Lifts Partial Hold On Hepatitis Drug IDX184; But Stock DownNASDAQ
Sacramento Bee
all 31 news articles »
Categories: In the News
Roundwood Doctor Nicola leads Hepatitis C reseach - Wicklow People
Roundwood Doctor Nicola leads Hepatitis C reseach
Wicklow People
Hepatitis C virus (HCV) is an RNA virus of the Flaviviridae family that poses a global health problem. Infection leads to progressive liver disease and has been associated with a variety of extrahepatic syndromes, including central nervous system (CNS) ...
Categories: In the News
Drug gives hope to hep C sufferers - Adelaide Now
Drug gives hope to hep C sufferers
Adelaide Now
A new drug is expected to boost the cure rate for the most common strain of hepatitis C. Source: The Courier-Mail A DRUG set to cure thousands of Australians with hepatitis has been hailed as a breakthrough. Victrelis has been approved by medicines ...
New Hep C treatment available in AustraliaHerald Sun
Hepatitis drug boost for patientsThe West Australian
Breakthrough in hepatitis treatmentThe Daily Telegraph
all 14 news articles »
Categories: In the News
Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C ... - MarketWatch (press release)
Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C ...
MarketWatch (press release)
"In addition to our expansive opportunity in hepatitis C, we continue to advance parallel strategies to address HIV, cancer, and sepsis." Beyond the opportunity to improve PR standard-of-care therapy, Hemopurifier® therapy may also benefit emerging ...
and more »
Categories: In the News
Stem cells could drive hepatitis research forward - MIT News
Stem cells could drive hepatitis research forward
MIT News
Hepatitis C, an infectious disease that can cause inflammation and organ failure, has different effects on different people. But no one is sure why some people are very susceptible to the infection, while others are resistant.
Stem Cells May Further Hepatitis C ResearchU.S. News & World Report
all 14 news articles »
Categories: In the News
Achillion, Idenix could miss hep-C merger bonanza - MarketWatch
Achillion, Idenix could miss hep-C merger bonanza
MarketWatch
By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Investors tantalized by a recent string of lucrative takeover offers for hepatitis C drug-developers shouldn't assume that an eye-popping bid for Idenix Pharmaceuticals and Achillion ...
Categories: In the News
Cell-permeable peptide that inhibits hepatitis C virus identified - TruthDive
Cell-permeable peptide that inhibits hepatitis C virus identified
TruthDive
Washington, Feb 1 (ANI): Researchers have now identified a cell-permeable peptide, which impedes a hepatitis C virus protein and blocks viral replication that can cause liver cancer and cirrhosis. This finding by Dr. Samuel French, an assistant ...
and more »
Categories: In the News
Prosecutor says doctor in hepatitis C outbreak is faking disabilities. - Las Vegas Review - Journal
Prosecutor says doctor in hepatitis C outbreak is faking disabilities.
Las Vegas Review - Journal
Desai, 62, is challenging state medical experts who found him competent to stand trial on criminal charges in the 2007 hepatitis C outbreak. » Buy this photo By Jeff German Dr. Dipak Desai, the physician at the center of the hepatitis C outbreak, ...
and more »
Categories: In the News
Awareness, Testing Needed to Curb Hep C Infections Among HIV-Positive Gay Men - AIDSmeds.com HIV/AIDS Treatment News
So So Gay
Awareness, Testing Needed to Curb Hep C Infections Among HIV-Positive Gay Men
AIDSmeds.com HIV/AIDS Treatment News
A new report by the National AIDS Trust (NAT), a leading HIV organization in the United Kingdom, concludes that much more needs to be done to address the burgeoning epidemic of hepatitis C virus (HCV) infection among gay men living with HIV.
HIV's Increasingly Dangerous SidekickSo So Gay
all 2 news articles »
Categories: In the News
New Hep C treatment available in Australia - Herald Sun
New Hep C treatment available in Australia
Herald Sun
A RECENTLY developed treatment for the most common form of hepatitis C has been approved for use in Australia by the Therapeutic Goods Administration (TGA). Victrelis, also known as boceprevir, comes from a group of drugs known as a protease inhibitors ...
New Hep C treatment in AustraliaAdelaide Now
Breakthrough in hepatitis treatmentThe Daily Telegraph
all 10 news articles »
Categories: In the News
Vertex Hep C Sales Growth Nears End - TheStreet.com
Vertex Hep C Sales Growth Nears End
TheStreet.com
(TheStreet) -- Vertex Pharmaceuticals'(VRTX) fourth-quarter earnings report Thursday may represent the high-water sales mark for the hepatitis C drug Incivek -- with prescriptions already declining just seven months after launch.
Vertex Falls as Analyst Cuts Hep C Sales Estimate: Boston MoverBusinessWeek
Vertex shares drop as analyst cools on high-flying hep C drugBoston Business Journal
Vertex Falls as analyst cuts sales estimates on hepatitis C pillBoston.com
LocalizedUSA
all 15 news articles »
Categories: In the News
Hepatitis C cases rise in Cortland - Ithaca Journal
Hepatitis C cases rise in Cortland
Ithaca Journal
CORTLAND -- An unusually high number of hepatitis C cases have been reported in Cortland County, according to the county Health Department, which has an investigation under way with the state Health Department. The hepatitis C virus affects the liver ...
and more »
Categories: In the News
© Lloyd Wright {dot} org